Diabetic Nephropathy
📧 Sign up to get email alerts when something new happens for Diabetic Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-09-09Clinical Trial Update: Aspirin and Renal Disease Progression in Patients With Type 2 Diabetes [Phase 3]
A Phase 3 clinical trial update examining aspirin's effect on renal disease progression in patients with type 2 diabetes. No results or stat…
-
CLINICAL_TRIALS research · 2016-08-24Clinical Trial Update: Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes Nephropathy [NA]
Clinical trial evaluating whether probucol combined with valsartan reduces proteinuria in diabetic nephropathy; sponsor Guangdong Provincial…
-
FDA approval · 2016-08-22FDA Approved: IRBESARTAN — Supplemental Application (Solco Healthcare U.S., LLC)
FDA approved a supplemental application for IRBESARTAN from Solco Healthcare U.S., LLC.
-
CLINICAL_TRIALS trial_result · 2016-08-15Clinical Trial Update: Microbial Soy Milk Consumption, Inflammation and Renal Function Among Type 2 Diabetic Patients With Nephropathy [NA]
A completed clinical trial evaluating whether microbial soy milk consumption influences inflammation and renal function in adults with type …
-
CLINICAL_TRIALS research · 2016-08-11Clinical Trial Update: Effects of High Dietary Fiber Supplementation in Diabetic Chronic Kidney Disease [NA]
This registry entry reports a completed clinical trial evaluating the effects of high dietary fiber supplementation in individuals with diab…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-08-09FDA Approved: IRBESARTAN — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' supplemental application for IRBESARTAN, a generic irbesartan product.
-
FDA approval · 2016-08-09FDA Approved: IRBESARTAN — Supplemental Application (NorthStar RxLLC)
FDA approved a supplemental application for IRBESARTAN by NorthStar RxLLC, approving an update to the already approved generic product.
-
CLINICAL_TRIALS trial_result · 2016-08-04Clinical Trial Update: Effect of Green Tea (Epigallocatechin Gallate) on Albuminuria in Patients With Diabetic Nephropathy. [Phase 2]
Phase 2 trial evaluating epigallocatechin gallate (green tea extract) on albuminuria in patients with diabetic nephropathy (with hypertensio…
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy [Phase 2]
A Phase 2 clinical trial evaluating N-acetylcysteine and milk thistle for diabetic nephropathy has completed.
-
FDA approval · 2016-06-14FDA Approved: IRBESARTAN — Original Application (Hisun Pharmaceuticals USA Inc.)
FDA approved the original application for IRBESARTAN (generic irbesartan) by Hisun Pharmaceuticals USA Inc., marking approval of the generic…
-
FDA approval · 2016-06-10FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Alembic Pharmaceuticals Limited)
The FDA approved a supplemental application for losartan potassium submitted by Alembic Pharmaceuticals Limited (ANDA 090428). This action u…
-
FDA approval · 2016-06-10FDA Approved: LOSARTAN POTASSIUM TABLETS, 25 MG — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)
FDA approved Jubilant Cadista Pharmaceuticals Inc. to market Losartan potassium tablets, 25 mg, as a generic product under an ANDA supplemen…
-
FDA approval · 2016-06-10FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' supplemental application for losartan potassium (generic), confirming an approved generic product.
-
CLINICAL_TRIALS research · 2016-06-10Clinical Trial Update: Measurement of Endothelial Function and Cardiac Output: New Methods
This report describes a completed clinical trial focused on new methods to measure endothelial function and cardiac output.
-
FDA approval · 2016-06-09FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for Losartan Potassium (generic) from Lupin Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2016-06-01Clinical Trial Update: Preventing ESRD in Overt Nephropathy of Type 2 Diabetes [Phase 3]
A Phase 3 trial evaluating prevention of end-stage renal disease in patients with type 2 diabetes and overt diabetic nephropathy has complet…
-
CLINICAL_TRIALS trial_result · 2016-06-01Clinical Trial Update: Renal Denervation in Diabetic Nephropathy [Phase 4]
A Phase 4 clinical trial evaluating renal denervation for diabetic nephropathy with persistent proteinuria has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-24Clinical Trial Update: Lipo-prostaglandin E1 Improves Renal Hypoxia Evaluated by BOLD-MRI in Patients With Diabetic Nephropathy [Phase 4]
A Phase 4 clinical trial found that Lipo-prostaglandin E1 improved renal oxygenation in patients with diabetic nephropathy, as measured by B…
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: The Differential Effects of Diabetes Therapy on Inflammation
This completed clinical trial examined how different diabetes therapies affect inflammation in people with Type 2 diabetes mellitus and Diab…
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy [Phase 3]
A Phase 3 trial evaluating Niaspan for dyslipidemia in patients with diabetic nephropathy was terminated. Results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-04-29Clinical Trial Update: Effect of LIXIsenatide on the Renal System [Phase 4]
Phase 4 trial evaluating the effect of lixisenatide on renal outcomes in patients with diabetic kidney disease and related conditions has be…
-
CLINICAL_TRIALS trial_result · 2016-04-13Clinical Trial Update: Matrix Metalloproteinases and Diabetic Nephropathy
The clinical trial investigating matrix metalloproteinases in diabetic nephropathy has completed, involving participants with Type 1 diabete…
-
CLINICAL_TRIALS trial_result · 2016-03-30Clinical Trial Update: The Effects of Bindarit in Diabetic Nephropathy [Phase 2]
Phase 2 trial update evaluating Bindarit for diabetic nephropathy.
-
CLINICAL_TRIALS trial_result · 2016-03-09Clinical Trial Update: Pyridorin in Diabetic Nephropathy [Phase 3]
A Phase 3 trial of Pyridorin for diabetic nephropathy was terminated, ending the study sponsored by NephroGenex, Inc.
-
FDA approval · 2016-02-28FDA Approved: RAMIPRIL — Supplemental Application (Chartwell RX, LLC.)
The FDA has approved a supplemental application for RAMIPRIL, allowing Chartwell RX, LLC to market a RAMIPRIL generic product.